Skip to main content

Conferences

Baroreflex Activation Therapy for HFrEF Patients: Long-Term Data and Real-World Experience at ESC 2023

  • Education, Video

At our ESC 2023 symposium, esteemed faculty Drs. William Abraham, Michael Zile, and Fernando Arribas shared their experiences with Barostim. Watch the videos below to learn more.

Unmet needs and opportunities with device therapies of HFrEF

Dr. William Abraham

BeAT-HF: Long-term outcomes

Dr. Michael Zile

Real-world experience with Baroreflex Activation Therapy

Dr. Fernando Arribas

The HCPs involved in this symposium have received compensation from CVRx for their participation.